The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 26, 2017
Filed:
May. 30, 2017
Applicant:
Abbvie Stemcentrx Llc, North Chicago, IL (US);
Inventors:
Robert A. Stull, Alameda, CA (US);
Laura Saunders, San Francisco, CA (US);
Scott J. Dylla, Emerald Hills, CA (US);
Orit Foord, Foster City, CA (US);
David Liu, San Francisco, CA (US);
Michael Torgov, Los Angeles, CA (US);
Hui Shao, Foster City, CA (US);
Assignee:
AbbVie Stemcentrx LLC, North Chicago, IL (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/18 (2006.01); C12P 21/08 (2006.01); A61K 47/48 (2006.01); C07K 16/30 (2006.01); A61K 31/5517 (2006.01); G01N 33/574 (2006.01); C07K 16/28 (2006.01); A61K 51/10 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48569 (2013.01); A61K 31/551 (2013.01); A61K 31/5517 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/48384 (2013.01); A61K 47/48407 (2013.01); A61K 47/48469 (2013.01); A61K 47/48538 (2013.01); A61K 47/48561 (2013.01); A61K 47/48592 (2013.01); A61K 47/48638 (2013.01); A61K 47/48715 (2013.01); A61K 47/48723 (2013.01); A61K 51/1096 (2013.01); C07K 16/18 (2013.01); C07K 16/28 (2013.01); C07K 16/2809 (2013.01); C07K 16/30 (2013.01); C07K 16/3023 (2013.01); C07K 16/3069 (2013.01); G01N 33/57423 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); A61K 2039/572 (2013.01); C07K 2317/20 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/35 (2013.01); C07K 2317/53 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/626 (2013.01); C07K 2317/70 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01); G01N 2333/70596 (2013.01);
Abstract
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.